Biocryst Pharmaceuticals buy HC Wainwright
Start price
04.08.23
/
50%
€6.90
Target price
04.08.24
€27.22
Performance (%)
-7.45%
End price
05.08.24
€6.39
Summary
This prediction ended on 05.08.24 with a price of €6.39. With a performance of -7.45%, the BUY prediction for Biocryst Pharmaceuticals by HC_Wainwright closed slightly in the red. HC_Wainwright has a follow-up prediction for Biocryst Pharmaceuticals where he still thinks Biocryst Pharmaceuticals is a Buy. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biocryst Pharmaceuticals | -1.354% | -1.354% | -0.753% |
| iShares Core DAX® | -5.585% | -6.284% | 8.869% |
| iShares Nasdaq 100 | -7.241% | -13.117% | 18.200% |
| iShares Nikkei 225® | -8.933% | -10.904% | 2.614% |
| iShares S&P 500 | -6.148% | -7.562% | 17.896% |
Comments by HC_Wainwright for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Ratings data for BCRX provided by MarketBeat
In the thread Trading Biocryst Pharmaceuticals
Die von HC_Wainwright gewählte maximale Laufzeit wurde überschritten
Current prediction by HC_Wainwright for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€4.98
07.05.24
07.05.24
€27.83
07.05.25
07.05.25
37.34%
11:31
11:31
